The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Virtual Advocacy Saves Time, Extends Reach

Virtual Advocacy Saves Time, Extends Reach

April 15, 2021 • By Kimberly Retzlaff

  • Tweet
  • Email
Print-Friendly Version / Save PDF

A few years ago, Mohammad Kamran, MD, a rheumatologist at Wellstar Health System in Marietta, Ga., got involved in advocacy as a way to help protect patients with rheumatic disease. The catalyst for his action was the tragic death of a patient, a 22-year-old Black woman with lupus. The young woman had been diagnosed years before, but because she was uninsured, she couldn’t afford medication or regular visits to her doctor. She was admitted to the hospital suffering from severe heart failure and kidney failure. Despite the healthcare team’s best efforts, she didn’t survive.

You Might Also Like
  • Capitol Hill Rheumatology Advocacy Goes Virtual
  • Participate in Virtual Capitol Hill Meetings with the ACR
  • Telehealth Extends Rheumatologists’ Reach
Also By This Author
  • Riding Out the Pandemic: A Q&A with Norman Gaylis, MD

Dr. Kamran decided he wasn’t going to complain—he was going to take action. Shortly after, he met with some of his state legislators to tell them about his patient and to talk about the challenges facing patients with rheumatic disease.

headshot of Mohammad Kamran

Dr. Kamran

Advocacy continues to be an important part of Dr. Kamran’s professional mission, and he recently joined the ACR Government Affairs Committee (GAC) to get involved at a higher level. He spoke with The Rheumatologist about his experience and why advocacy is critical during the COVID-19 pandemic and beyond.

The Rheumatologist (TR): Why is advocacy still important in the midst of a public health emergency?

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Dr. Kamran: This pandemic is different than any other public health emergency would be. I mean, it’s kept everybody at home. Everything changed, so advocacy even became more important to educate our legislators, bring forth the problems that we will be facing or that we are facing and talk to them about how they can help us navigate those problems.

TR: How has the COVID-19 pandemic changed how you approach rheumatology advocacy?

Dr. Kamran: The pandemic may have made it a little easier, ironically. Previously, if I was going to go to the Hill, I had to close my office and take time off for in-person meetings. In-person meetings are very productive, and I would love to go back to that as well, but what is different is now it is easier to get involved because we can advocate virtually without leaving our offices or hometowns. This way one can be more involved and reach out to more legislators.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

TR: Does your position in a large, multi-specialty group in Georgia affect how you approach advocacy?

Dr. Kamran: No. I always keep the patients in the forefront. They are the center, and they should be the center of everything we do and advocate for.

Pages: 1 2 | Single Page

Filed Under: Legislation & Advocacy, Profiles Tagged With: Advocacy, Government Affairs Committee (GAC), Mohammad Kamran

You Might Also Like:
  • Capitol Hill Rheumatology Advocacy Goes Virtual
  • Participate in Virtual Capitol Hill Meetings with the ACR
  • Telehealth Extends Rheumatologists’ Reach
  • Advocacy: An essential component of professional practice

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2022 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)